Back
Speaker illustration

undefined undefined undefined

Presentations

Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry

Event: ESC Congress 2018

Topic: Heart Failure in Atrial Fibrillation

Session: Atrial fibrillation - Epidemiology prognosis outcome

Access
Like
Thumbnail

Baseline characteristics of patients with atrial fibrillation with and without comorbid heart failure: the GLORIA-AF registry

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Clinical and epidemiological aspects (Atrial Fibrillation)

Session: Atrial Fibrillation - Clinical and epidemiological aspects

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources